Market Tracker

11/21 6:05pm ET

Novo Nordisk A/S (NYSE:NVO)

44.29
Data as of Nov 21
 -0.06 / -0.14%
Today’s Change
34.30
Today|||52-Week Range
49.11
+19.86%
Year-to-Date
No recent news for Novo Nordisk A/S.

Today’s Trading

Previous close44.35
Today’s open44.50
Day’s range44.09 - 44.56
Volume680,508
Average volume (3 months)1,459,041
Market cap$91.4B
Dividend yield1.87%
Data as of 4:03pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+23.61%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.90%
Revenue growth (last year)+10.11%
P/E ratio--
Price/Sales6.64
Price/Book14.91

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca PLC+0.35+0.47%
CELGCelgene Corp+0.85+0.79%
BMYBristol-Myers Squibb...+0.19+0.32%
ABBVAbbVie Inc+2.17+3.33%
Data as of 4:06pm ET, 11/21/2014

Financials

Next reporting dateJanuary 30, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$14.9B
Annual profit (last year)$4.5B
Net profit margin30.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts